These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 30308028)

  • 1. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
    Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
    PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
    Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
    Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice.
    Belcher JD; Young M; Chen C; Nguyen J; Burhop K; Tran P; Vercellotti GM
    Blood; 2013 Oct; 122(15):2757-64. PubMed ID: 23908468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease.
    Beckman JD; Belcher JD; Vineyard JV; Chen C; Nguyen J; Nwaneri MO; O'Sullivan MG; Gulbahce E; Hebbel RP; Vercellotti GM
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1243-53. PubMed ID: 19617415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
    PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
    Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
    Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
    Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
    Front Immunol; 2020; 11():613278. PubMed ID: 33542720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.
    Vercellotti GM; Zhang P; Nguyen J; Abdulla F; Chen C; Nguyen P; Nowotny C; Steer CJ; Smith A; Belcher JD
    Mol Med; 2016 Sep; 22():437-451. PubMed ID: 27451971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin Completely Ameliorates Hypoxia-Reoxygenation-Induced Pathophysiology Severity in NY1DD Transgenic Sickle Mice: Intrinsic Mild Steady State Pathophysiology of the Disease in NY1DD Is Also Reversed.
    Thangaswamy S; Branch CA; Ambadipudi K; Acharya SA
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.
    Belcher JD; Mahaseth H; Welch TE; Otterbein LE; Hebbel RP; Vercellotti GM
    J Clin Invest; 2006 Mar; 116(3):808-16. PubMed ID: 16485041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.
    Gbotosho OT; Kapetanaki MG; Ghosh S; Villanueva FS; Ofori-Acquah SF; Kato GJ
    Front Immunol; 2020; 11():1910. PubMed ID: 32973791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
    Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
    Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles.
    Jana S; Strader MB; Meng F; Hicks W; Kassa T; Tarandovskiy I; De Paoli S; Simak J; Heaven MR; Belcher JD; Vercellotti GM; Alayash AI
    JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease.
    Belcher JD; Nataraja S; Abdulla F; Zhang P; Chen C; Nguyen J; Ruan C; Singh M; Demes S; Olson L; Stickens D; Stanwix J; Clarke E; Huang Y; Biddle M; Vercellotti GM
    Front Med (Lausanne); 2023; 10():1101501. PubMed ID: 37144034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity.
    Bains SK; Foresti R; Howard J; Atwal S; Green CJ; Motterlini R
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):305-12. PubMed ID: 19965783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oral carbon monoxide-releasing molecule protects against acute hyperhemolysis in sickle cell disease.
    Nguyen KA; Matte A; Foresti R; Federti E; Kiger L; Lefebvre C; Hocini H; Pelinski Y; Kitagishi H; Bencheikh L; Pirenne F; de Franceschi L; Motterlini R; Bartolucci P
    Blood; 2024 Jun; 143(24):2544-2558. PubMed ID: 38518106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.
    Schmidt HM; Wood KC; Lewis SE; Hahn SA; Williams XM; McMahon B; Baust JJ; Yuan S; Bachman TN; Wang Y; Oh JY; Ghosh S; Ofori-Acquah SF; Lebensburger JD; Patel RP; Du J; Vitturi DA; Kelley EE; Straub AC
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):769-782. PubMed ID: 33267657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease.
    Belcher JD; Vineyard JV; Bruzzone CM; Chen C; Beckman JD; Nguyen J; Steer CJ; Vercellotti GM
    J Mol Med (Berl); 2010 Jul; 88(7):665-75. PubMed ID: 20306336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.